 |
 |

Evaluation and Treatment of Primary Hyperparathyroidism
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: In the Clinical Crossroads discussing a patient with primary hyperparathyroidism, Dr Strewler1 did not mention the intake of thiazide diuretics in the differential diagnosis of hypercalcemia. This is particularly important in cases of suspected primary hyperparathyroidism in which thiazide therapy may have an impact on disease management.
Thiazide diuretics can increase serum calcium levels by complex mechanisms that include a decrease in urinary calcium excretion,2-3 enhancement of parathyroid hormone action,2-3 and possibly an increase in intestinal calcium absorption and bone resorption.4 In healthy persons with normal calcium homeostasis, the increase in serum calcium with thiazide intake is generally mild and transient, in the range of 0.5 to 1 mg/dL (0.12-0.25 mmol/L), lasting 4 to 6 weeks.3-4 However, in patients with underlying hyperparathyroidism, thiazide use typically uncovers or aggravates the hypercalcemia.3, 5 In this setting, overestimation of hypercalcemia as a result of thiazide intake may lead to unnecessary patient . . . [Full Text of this Article]
Nasser Mikhail, MD, MSc
nmikhail@ladhs.org Department of Endocrinology
Dennis Cope, MD
Department of Medicine Olive View-UCLA Medical Center Sylmar, Calif
RELATED ARTICLES
Evaluation and Treatment of Primary Hyperparathyroidism
Andrew Grey, Mark Bolland, and Ian R. Reid
JAMA. 2005;294(21):2699-2700.
EXTRACT
| FULL TEXT
A 64-Year-Old Woman With Primary Hyperparathyroidism
Gordon J. Strewler
JAMA. 2005;293(14):1772-1779.
EXTRACT
| FULL TEXT
|